Taken together, these characteristics of different breast tumor subtypes may contribute to a high likelihood of metastasis even after RT, but there is still a slightly favorable outcome observed after RT in luminal A (HR+/HER2-) breast tumors. The gene discussed is ERBB2; the disease is breast neoplasm.